- Home
- SRZN vs PRE Comparison
SRZN vs PRE Comparison
Compare SRZN & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- PRE
- Stock Information
- Founded
- SRZN 2015
- PRE 2014
- Country
- SRZN United States
- PRE Hong Kong
- Employees
- SRZN N/A
- PRE N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- SRZN Health Care
- PRE Industrials
- Exchange
- SRZN Nasdaq
- PRE Nasdaq
- Market Cap
- SRZN 97.3M
- PRE 102.7M
- IPO Year
- SRZN N/A
- PRE N/A
- Fundamental
- Price
- SRZN $12.55
- PRE $8.00
- Analyst Decision
- SRZN Strong Buy
- PRE Buy
- Analyst Count
- SRZN 2
- PRE 1
- Target Price
- SRZN $38.50
- PRE $9.00
- AVG Volume (30 Days)
- SRZN 16.1K
- PRE 38.8K
- Earning Date
- SRZN 08-08-2025
- PRE 10-06-2025
- Dividend Yield
- SRZN N/A
- PRE N/A
- EPS Growth
- SRZN N/A
- PRE N/A
- EPS
- SRZN N/A
- PRE N/A
- Revenue
- SRZN $12,621,000.00
- PRE $41,520,000.00
- Revenue This Year
- SRZN N/A
- PRE $198.17
- Revenue Next Year
- SRZN N/A
- PRE $59.73
- P/E Ratio
- SRZN N/A
- PRE N/A
- Revenue Growth
- SRZN N/A
- PRE 78.72
- 52 Week Low
- SRZN $5.90
- PRE $3.10
- 52 Week High
- SRZN $18.17
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- SRZN 70.80
- PRE 54.41
- Support Level
- SRZN $10.73
- PRE $7.27
- Resistance Level
- SRZN $11.88
- PRE $8.84
- Average True Range (ATR)
- SRZN 0.73
- PRE 0.37
- MACD
- SRZN 0.09
- PRE 0.08
- Stochastic Oscillator
- SRZN 74.09
- PRE 45.95
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.